These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20033906)

  • 21. Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.
    Brimo F; Aprikian A; Latour M; Têtu B; Doueik A; Scarlata E; Hamel L; McKercher G; Saad F; Lacombe L; Carmel M; Chevalier S
    Biopreserv Biobank; 2013 Oct; 11(5):285-90. PubMed ID: 24194978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate.
    Levin YS; Albers MJ; Butler TN; Spielman D; Peehl DM; Kurhanewicz J
    Magn Reson Med; 2009 Nov; 62(5):1091-8. PubMed ID: 19780158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
    Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
    World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.
    Cheng LL; Burns MA; Taylor JL; He W; Halpern EF; McDougal WS; Wu CL
    Cancer Res; 2005 Apr; 65(8):3030-4. PubMed ID: 15833828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.
    Arsov C; Becker N; Rabenalt R; Hiester A; Quentin M; Dietzel F; Antoch G; Gabbert HE; Albers P; Schimmöller L
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2061-8. PubMed ID: 26013424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
    Calio BP; Sidana A; Sugano D; Gaur S; Maruf M; Jain AL; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    J Urol; 2018 Apr; 199(4):976-982. PubMed ID: 29154904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
    Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
    Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies.
    Mirnezami R; Jiménez B; Li JV; Kinross JM; Veselkov K; Goldin RD; Holmes E; Nicholson JK; Darzi A
    Ann Surg; 2014 Jun; 259(6):1138-49. PubMed ID: 23860197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
    Braadland PR; Giskeødegård G; Sandsmark E; Bertilsson H; Euceda LR; Hansen AF; Guldvik IJ; Selnæs KM; Grytli HH; Katz B; Svindland A; Bathen TF; Eri LM; Nygård S; Berge V; Taskén KA; Tessem MB
    Br J Cancer; 2017 Nov; 117(11):1656-1664. PubMed ID: 28972967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
    Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
    Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semi-parametric time-domain quantification of HR-MAS data from prostate tissue.
    Ratiney H; Albers MJ; Rabeson H; Kurhanewicz J
    NMR Biomed; 2010 Dec; 23(10):1146-57. PubMed ID: 20842756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy.
    Li M; Song Y; Cho N; Chang JM; Koo HR; Yi A; Kim H; Park S; Moon WK
    PLoS One; 2011; 6(10):e25563. PubMed ID: 22028780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating High-Resolution and Solid-State Magic Angle Spinning NMR Spectroscopy and a Transcriptomic Analysis of Soybean Tissues in Response to Water Deficiency.
    Coutinho ID; Moraes TB; Mertz-Henning LM; Nepomuceno AL; Giordani W; Marcolino-Gomes J; Santagneli S; Colnago LA
    Phytochem Anal; 2017 Nov; 28(6):529-540. PubMed ID: 28722224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
    Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
    BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system.
    Alqahtani S; Wei C; Zhang Y; Szewczyk-Bieda M; Wilson J; Huang Z; Nabi G
    Sci Rep; 2020 May; 10(1):7722. PubMed ID: 32382097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations.
    Panebianco V; Sciarra A; De Berardinis E; Busetto GM; Lisi D; Buonocore V; Gentile V; Di Silverio F; Passariello R
    Anticancer Res; 2011 Apr; 31(4):1399-405. PubMed ID: 21508392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.